| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |